These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 478639)

  • 21. In vitro lymphocyte reactivity to rubella antigen following vaccination.
    Heigl Z; Wasserman J; Forsgren M
    Scand J Infect Dis; 1980; 12(1):13-20. PubMed ID: 6988953
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Suppression of the response of lymphocytes to phytohemagglutinin in rubella.
    McMorrow LE; Vesikari T; Wolman SR; Giles JP; Cooper LZ
    J Infect Dis; 1974 Nov; 130(5):464-9. PubMed ID: 4423757
    [No Abstract]   [Full Text] [Related]  

  • 23. Replication of rubella virus in human mononuclear blood cells.
    van der Logt JT; van Loon AM; van der Veen J
    Infect Immun; 1980 Feb; 27(2):309-14. PubMed ID: 6155330
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Persistent rubella infection and rubella-associated arthritis.
    Chantler JK; Ford DK; Tingle AJ
    Lancet; 1982 Jun; 1(8285):1323-5. PubMed ID: 6123637
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Development of immunoglobulin M-antibodies after rubella immunization with RA27/3 attenuated live vaccine in teen-agers: remaining problems.
    Braito A; Fanti O; Rossolini GM; Cellesi C
    Boll Ist Sieroter Milan; 1991-1992; 70(1-2):443-8. PubMed ID: 1670047
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interferon production in lymphocyte cultures after rubella infection in humans.
    Buimovici-Klein E; Weiss KE; Cooper LZ
    J Infect Dis; 1977 Mar; 135(3):380-5. PubMed ID: 850076
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Factors associated with clinical reactions to rubella vaccination in women.
    Nakazono N; Fujimoto S; Wakisaka A; Ishii K; Ichinoe K; Aizawa M
    Int J Gynaecol Obstet; 1987 Jun; 25(3):207-16. PubMed ID: 2886379
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Response of human immunodeficiency virus-infected adults to measles-rubella vaccination.
    Sprauer MA; Markowitz LE; Nicholson JK; Holman RC; Deforest A; Dales LG; Khoury NK
    J Acquir Immune Defic Syndr (1988); 1993 Sep; 6(9):1013-6. PubMed ID: 8340890
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Depressed lymphocyte function after measles-mumps-rubella vaccination.
    Munyer TP; Mangi RJ; Dolan T; Kantor FS
    J Infect Dis; 1975 Jul; 132(1):75-8. PubMed ID: 1151122
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Duration of rubella immunity induced by two-dose measles, mumps and rubella (MMR) vaccination. A 15-year follow-up in Finland.
    Davidkin I; Peltola H; Leinikki P; Valle M
    Vaccine; 2000 Jul; 18(27):3106-12. PubMed ID: 10856790
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cell-mediated immune response in rubella infections.
    Buimovici-Klein E; Cooper LZ
    Rev Infect Dis; 1985; 7 Suppl 1():S123-8. PubMed ID: 2408312
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Elastic transformation in presence of tuberculin antigens of lymphocytes of children vaccinated against rubella].
    Moschini L; Businco L; Midulla M
    Minerva Pediatr; 1971 Mar; 23(9):375-8. PubMed ID: 5574425
    [No Abstract]   [Full Text] [Related]  

  • 33. Antibody response to rubella ribonucleoprotein component after natural infection and after immunization.
    Ho-Terry L; Cohen A
    J Med Microbiol; 1981 Feb; 14(1):141-5. PubMed ID: 7463463
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Study of young women vaccinated against rubella virus for 10 years in Taiwan.
    Lin DB; Kao CL; Lee CY
    Southeast Asian J Trop Med Public Health; 1996 Dec; 27(4):707-14. PubMed ID: 9253871
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Isolation of rubella virus from human lymphocytes after acute natural infection.
    Chantler JK; Tingle AJ
    J Infect Dis; 1982 May; 145(5):673-7. PubMed ID: 7077092
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immune response after primary and re-vaccination with different combined vaccines against measles, mumps, rubella.
    Tischer A; Gerike E
    Vaccine; 2000 Jan; 18(14):1382-92. PubMed ID: 10618536
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Biological view of vaccination described by mathematical modellings: from rubella to dengue vaccines.
    Yang MH; Freitas ARR
    Math Biosci Eng; 2019 Apr; 16(4):3195-3214. PubMed ID: 31499609
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A search for persistent measles, mumps, and rubella vaccine virus in children with human immunodeficiency virus type 1 infection.
    Frenkel LM; Nielsen K; Garakian A; Cherry JD
    Arch Pediatr Adolesc Med; 1994 Jan; 148(1):57-60. PubMed ID: 8143011
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of low level immunity on response to live rubella virus vaccine.
    Väänänen P; Mäkelä P; Vaheri A
    Vaccine; 1986 Mar; 4(1):5-8. PubMed ID: 3962450
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Avidity of immunoglobulin G to rubella virus in post-vaccination and post-infection immunity].
    Desiatskova RG; Zargar'iants AI; Stepanov AV; Zverev VV
    Zh Mikrobiol Epidemiol Immunobiol; 2007; (4):6-11. PubMed ID: 17882830
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.